MIAMI, Florida, October 28, 2022 – The International Society for Stem Cell Application (ISSCA) is excited to announce a regenerative medicine conference in Pakistan. This event will occur on June 10th, 2023, at the University of Lahore
ISSCA is a global brand and a top leader in Regenerative Medicine worldwide. This society has partnered with other organizations in this field to host a symposium in Pakistan. Other key contributors are the Academy of Aesthetic and Regenerative Medicine (AARM), the University of Lahore (UOL), and the University College of Medicine and Dentistry (UCMD).
Goals of the Regenerative Medicine Conference 2023
The primary goal of this symposium is to encourage more physicians to adopt regenerative medicine in their practices. It also aims at improving the availability of such services to patients worldwide.
The regenerative medicine conference will benefit specialists and physicians that want to advance their studies in this field. Besides, it will provide the participants with more information about modern regenerative medicine products.
The conference will also help specialists access advanced technologies and understand their role in developing solutions in the medical field.
Regenerative medicine is growing at an undeniable rapid rate. As researchers continue to explore the field, they are discovering and developing more products. Specialists are also incorporating these discoveries into their clinics and offices worldwide. The symposium will help participants keep up with the exponential growth and changes in regenerative medicine.
What to Expect During the Symposium in Pakistan
The conference in Pakistan will consist of two sections, a theoretical and a practical one.
- Theoretical portion- World-class medical specialists will educate participants by sharing their experience and knowledge in regenerative medicine.
- Practical part- This session will include training on aesthetic and clinical applications of stem cell therapy. Participating physicians will also learn the best protocols for developing a safe and efficient medical practice.
If you want information on the upcoming regenerative medicine conference in Pakistan, visit https://www.issca.us.
What Dr. Fahad Usman Has to Say About This Event
Dr. Fahad Usman is the president of the Academy Of Aesthetic and Regenerative Medicine and the Director Center For Aesthetic Medicine University Of Lahore (UOL).
Here is what he has to say about the upcoming symposium- ‘This collaboration will identify new horizons for Regenerative Medicine in Pakistan. The event will not only benefit the doctors’ community in the country by putting Regenerative Medicine on the canvas but also increase business opportunities for investors looking for a new market for stem cell technology.
What Benito Novas Has to Say About the ISSCA
Benito Novas is the CEO of Global Stem Cells Group and Managing director of the International Society for Stem Cell Application (ISSCA). As a leader in regenerative medicine, he agrees the partnership aligns with the company’s extension plan.
Here is what he has to say- ‘The main aim of ISSCA is to spread the benefits of regenerative medicine throughout the world. We are committed to helping physicians and patients around the globe benefit from regenerative medicine
Conference Sponsors
ISSCA recognizes the significance of the 2023 Pakistan symposium in the growth of regenerative medicine. Hence, it’s grateful to the following key sponsors:
- Global Stem Cells Group
- N-Biotek
- Biotrend
- University College of Medicine and Dentistry (UCMD)
About ISSCA
The International Society for Stem Cell Application is a diverse community of physicians and scientists. The members of this nonprofit organization aspire to lessen human suffering by treating diseases. Likewise, they aim to utilize advanced science, regenerative medicine practices, and technology to offer better treatments.
ISSCA benefits its members by supporting and facilitating the advancement of regenerative medicine. The vision of this society is to be a recognized leader that promotes excellence while setting standards in various fields of regenerative medicine. Such include:
- Research
- Certification
- Publication
- Training
ISSCA recognizes the importance of certification and medical standards. That’s why it’s holding the Regenerative Medicine Conference in Pakistan. ISSCA also offers certification training in all cities worldwide.
If you want to advance your studies in regenerative medicine, plan to attend this conference.
About Global Stem Cell Group (GSCG)
The Global Stem Cell group comprises several companies dedicated to stem cell research and medicine. GSCG wants to increase patients’ access to advancements in this field. The company is also a reliable source of innovation and knowledge on the roles of stem cells in modern medicine.
GSCG liaises with educators, physicians, policymakers, and regulators to promote stem cell technology. Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
